Sexcord/ stromal ovarian tumors epidemiology and demographics: Difference between revisions
(→Age) |
(→Age) |
||
Line 24: | Line 24: | ||
*They are more likely to occur in postmenopausal women | *They are more likely to occur in postmenopausal women | ||
Sclerosing stromal tumor(SSTs): | Sclerosing stromal tumor(SSTs): | ||
*SSTs are more likely to occur in young women | *SSTs are more likely to occur in young women | ||
*Approximately 80% of the reported cases are under 30 years of age | *Approximately 80% of the reported cases are under 30 years of age | ||
*A few cases have been reported in premenarchal girls, although SSTs most commonly occur after menarche | *A few cases have been reported in premenarchal girls, although SSTs most commonly occur after menarche | ||
Steroid cell tumors: | |||
*The average age of presentation is 43 years | |||
Adult and juvenile granulosa cell tumors: | |||
*The incidence of adult granulosa cell tumors peaks in early postmenopausal women | |||
*The juvenile form occurs predominantly in children and young women (<30 years) | |||
===Race=== | ===Race=== |
Revision as of 16:31, 29 March 2019
Sexcord/ stromal ovarian tumors Microchapters |
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sexcord/ stromal ovarian tumors epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors epidemiology and demographics |
FDA on Sexcord/ stromal ovarian tumors epidemiology and demographics |
CDC on Sexcord/ stromal ovarian tumors epidemiology and demographics |
Sexcord/ stromal ovarian tumors epidemiology and demographics in the news |
Blogs on Sexcord/ stromal ovarian tumors epidemiology and demographics |
Risk calculators and risk factors for Sexcord/ stromal ovarian tumors epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
Ovarian sex cord-stromal tumors are very uncommon neoplasms that represent only 7% of all ovarian tumors
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
Fibromas:
- Although they can present at any age, the mean age of occurrence is in the late forties
Thecomas:
- They are more likely to occur in postmenopausal women
Sclerosing stromal tumor(SSTs):
- SSTs are more likely to occur in young women
- Approximately 80% of the reported cases are under 30 years of age
- A few cases have been reported in premenarchal girls, although SSTs most commonly occur after menarche
Steroid cell tumors:
- The average age of presentation is 43 years
Adult and juvenile granulosa cell tumors:
- The incidence of adult granulosa cell tumors peaks in early postmenopausal women
- The juvenile form occurs predominantly in children and young women (<30 years)
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].